Image Source: Anna Tarazevich
A recent survey by the Prostate Cancer Foundation New Zealand (PCFNZ) has revealed that 93% of prostate cancer survivors in the country experience erectile dysfunction (ED) following treatment.
Many of these men report that their condition remains untreated, highlighting the ongoing challenges they face in their recovery. Released on 5 November 2024, the study sheds light on the significant physical and emotional hurdles that continue to affect survivors long after their treatment ends.
The Scope of the Problem
The Prostate Cancer Foundation survey paints a concerning picture of the impact of erectile dysfunction (ED) on men following prostate cancer treatment. Mental health issues, such as anxiety and depression, were reported by 28% of survivors, while others cited strained relationships as a result of changes in intimacy.
The survey also found that 93 per cent of men who have ED often report a loss of self-confidence, making it harder for men to adjust after cancer. Despite these challenges, many participants indicated they had not been adequately informed about the risks of ED during their treatment or diagnosis.
Mike, 73, from Tauranga, was diagnosed with ED and UI following prostate cancer surgery in 2016. While his UI improved in the months following surgery, ED continued to affect his quality of life. “Dealing with prostate cancer was tough, but the added complications from surgery made things even harder,” Mike said. He set a goal to stop using incontinence pads, and with time, his symptoms improved. However, ED remained a struggle.
Expert Perspectives on Treating and Managing ED After Cancer
Peter Dickens, Chief Executive Officer of PCFNZ, shared that many prostate cancer survivors experience significant disruptions to their quality of life due to erectile dysfunction (ED) and urinary incontinence (UI) after treatment. Survey results show that 69% of men experience ED frequently, while 78% report UI, with nearly half describing their symptoms as moderate to severe.
Despite this, more than 40% of men were not informed about the possibility of ED after treatment. Mr Dickens urged men and their families across the country to attend the “Prostate Cancer: Life After Treatment” public information sessions to learn about available treatment and management options.
Urologist Mr Giovanni Losco, Clinical Director of Urology at Health New Zealand Te Whatu Ora Waitaha Canterbury, noted that erectile dysfunction (ED) is a common outcome of prostate cancer surgery. He emphasised that while the cancer may be treated successfully, many men who don’t seek help for ED may face long-term difficulties with sexual function.
Professor Helen O’Connell, AO, President of the Urological Society of Australia and New Zealand (USANZ), highlighted the importance of informing men with prostate cancer or at risk of it that effective treatments for erectile dysfunction (ED) exist. “As USANZ President, I want men to know that ED and urinary incontinence are serious health issues,” she explained.
PCFNZ’s “Life After Treatment” Roadshow
In response to the survey findings, the Prostate Cancer Foundation New Zealand (PCFNZ) has launched the “Life After Treatment” roadshow. The initiative, starting in Tauranga, will travel to major cities across Aotearoa to provide prostate cancer survivors with information and resources.
The roadshow will include expert-led sessions on managing erectile dysfunction (ED) and other treatment side effects, as well as guidance on mental health and relationship support.
Prostate cancer continues to be the most common cancer in New Zealand, with thousands of men diagnosed each year. While treatment has saved lives, the widespread issue of erectile dysfunction (ED) among survivors underscores the importance of comprehensive post-treatment care. Initiatives like the PCFNZ roadshow are critical for raising awareness and providing the support survivors need.